References
- WHO. Position paper on hepatitis A vaccines. Wkly Epidemiol Rec. 2012;87(28/29):261-76. PMID:22905367
- Ciocca M, Ramonet M, Cuarterolo M, Lopez S, Speranza A, Imventarza O, Alvarez F. Acute liver failure in children: experience with 210 patients. J Pediatr Gastroenterol Nutr. 2004;39:S31. doi:10.1097/00005176-200406001-00064
- Bernal W, Wendon J. Acute liver failure. New Eng J Med. 2013;369(26):2525-34. doi:10.1056/NEJMra1208937. PMID:24369077
- Lopez E, Debbag R, Coudeville L, Baron-Papillon F, Armoni J. The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis. J Gastroenterol. 2007;42(2):152-60. doi:10.1007/s00535-006-1984-x. PMID:17351805
- Gentile A, Ramonet MD, Ciocca M. [Hepatitis A immunisation in the Argentinean mandatory schedule]. Arch Argent Pediatr. 2013;111(2):155-61. doi:10.5546/aap.2013.155. PMID:23568072
- Vizzotti C, Gonzalez J, Rearte A, Uruena A, Perez Carrega M, Calli R, Gentile A, Uboldi A, Ramonet M, Cañero-Velasco M, et al. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years. J Pediatric Infect Dis Soc. 2015;4(4):e62-7. doi:10.1093/jpids/piu068. PMID:26582885
- Vizzotti C, Gonzalez J, Gentile A, Rearte A, Ramonet M, Canero-Velasco MC, Pérez Carrega ME, Urueña A, Diosque M. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr Inf Dis J. 2014;33(1):84-8. doi:10.1097/INF.0000000000000042
- Iwarson S, Lindh M, Widerstrom L. Excellent booster response 4-6 y after a single primary dose of an inactivated hepatitis A vaccine. Scand J Infect Dis. 2002;34(2):110-1. doi:10.1080/00365540110077362. PMID:11928839
- Van Herck K, Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol. 2001;63(1):1-7. doi:10.1002/1096-9071(200101)63:1%3c1::AID-JMV1000%3e3.0.CO;2-U. PMID:11130881
- Espul C, Benedetti L, Cuello H, Houillon G, Rasuli A. Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina. Hepat Med. 2012;4:53-60. doi:10.2147/HMER.S33847. PMID:24367232
- Espul C, Benedetti L, Linares M, Cuello H, Rasuli A. Five-year follow-up of immune response after one or two doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina. J Viral Hepat. 2015;22(4):453-8. doi:10.1111/jvh.12317. PMID:25262590
- Berger R, Just M, Althaus B. Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used. J Virol Methods. 1993;43(3):287-97. doi:10.1016/0166-0934(93)90147-J. PMID:8408443
- Miller WJ, Clark W, Hurni W, Kuter B, Schofield T, Nalin D. Sensitive assays for hepatitis A antibodies. J Med Virol. 1993;41(3):201-4. doi:10.1002/jmv.1890410306. PMID:8263501
- Wiedmann M, Boehm S, Schumacher W, Swysen C, Zauke M. Evaluation of three commercial assays for the detection of hepatitis a virus. Eur J Clin Microbiol Infect Dis. 2003;22(2):129-30. PMID:12627291
- Advisory Committee on Immunization Practices, Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortality Wkly Rep. 2006;55(RR-7):1-23
- Lemon SM, Binn LN. Serum neutralizing antibody response to hepatitis A virus. J Infect Dis. 1983;148(6):1033-9. doi:10.1093/infdis/148.6.1033. PMID:6317766
- Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, Shouval D, Bonanni P, Connor B, Cooksley G, et al. Hepatitis A booster vaccination: is there a need? Lancet. 2003;362(9389):1065-71
- Newcombe RG. Two-sided confidence intervals for the single proportion: Comparison of seven methods. Stat Med. 1998;17(8):857-72. doi:10.1002/(SICI)1097-0258(19980430)17:8%3c857::AID-SIM777%3e3.0.CO;2-E. PMID:9595616